AQR Capital Management
GBIO

AQR Capital Management’s Generation Bio GBIO Stock Holding History

AQR Capital Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,369
Closed -$20.4K – 3507
2025
Q2 		$20.4K Sell
6,369
-2,532
-28% -$9.75K ﹤0.01% 3282
2025
Q1 		$36K Buy
+8,901
New +$62.5K ﹤0.01% 3100
2022
Q4 		– Sell
-3,262
Closed -$173K – 2229
2022
Q3 		$173K Buy
+3,262
New +$204K ﹤0.01% 2065

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AQR Capital Management's GBIO Position: Q3 2025 in Review

AQR Capital Management sold out of Generation Bio (GBIO) in Q3 2025, closing a stake of 6,369 shares — an estimated $20.4K sold.

AQR Capital Management first reported a position in GBIO in Q3 2022 and held it in 3 quarters. The position peaked at $173K in Q3 2022. 41 funds tracked by Wall St. Rank hold GBIO as of Q3 2025.

  • AQR Capital Management reported no remaining Generation Bio position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 6,369 Generation Bio shares in Q3 2025, an estimated $20.4K.
  • AQR Capital Management first reported a position in Generation Bio in Q3 2022 and held it in 3 quarters.
  • AQR Capital Management's Generation Bio position peaked at $173K in Q3 2022.
  • 41 funds tracked by Wall St. Rank held Generation Bio as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.